Revvity's recurring revenue base from consumables, services, and software ensures predictable income. Read why RVTY stock is ...

Check the time stamp on this data. Updated AI-Generated Signals for Revvity Inc. (RVTY) available here: RVTY.

Modern drug discovery and biosimilar development projects generate very large volumes of data, yet results held in ...

Revvity, Inc. (NYSE:RVTY – Free Report) – Stock analysts at Zacks Research lifted their FY2024 EPS estimates for shares of Revvity in a report issued on Monday, November 25th. Zacks Research ...

Shares of Revvity Inc. RVTY inched 0.36% higher to $115.07 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.57% to ...

Revvity, Inc. (NYSE: RVTY), announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance critical genomic initiatives across the ...

Barclays analyst Luke Sergott lowered the firm’s price target on Revvity (RVTY) to $135 from $140 and keeps an Overweight rating on the shares following the investor day. The company oulined ...